| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2123758 | European Journal of Cancer | 2009 | 9 Pages |
Abstract
System-based models can be used to identify a set of baseline features that are associated with reduced overall survival in patients with NSCLC treated with gefitinib. This is a preliminary study, and further analyses are required to validate the model in a randomised, controlled treatment setting.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Michael J. Donovan, Angeliki Kotsianti, Valentina Bayer-Zubek, David Verbel, Mikhail Teverovskiy, Carlos Cordon-Cardo, Jose Costa, F. Anthony Greco, John D. Hainsworth, Dinah V. Parums,